---
title: "NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization | NRXBF Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281889726.md"
description: "NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization | NRXBF Stock News"
datetime: "2026-04-07T05:20:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281889726.md)
  - [en](https://longbridge.com/en/news/281889726.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281889726.md)
---

# NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization | NRXBF Stock News

NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization | NRXBF Stock News

### Related Stocks

- [ABCL.US](https://longbridge.com/en/quote/ABCL.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [ADMA.US](https://longbridge.com/en/quote/ADMA.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ERNA.US](https://longbridge.com/en/quote/ERNA.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Abcellera director John S. Montalbano acquires common shares worth $110,300](https://longbridge.com/en/news/296260315.md)
- [12:10 ETBerger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA)](https://longbridge.com/en/news/296129253.md)
- [What's Going on With AbCellera Biologics Stock On Wednesday?](https://longbridge.com/en/news/295696830.md)
- [AbCellera Announces Pricing of Oversubscribed $200 Million Public Offering of Common Shares and Pre-Funded Warrants | ABCL Stock News](https://longbridge.com/en/news/295741148.md)
- [BUZZ-AbCellera slips after launching $200 mln stock offering to fund menopause drug](https://longbridge.com/en/news/295575515.md)